Study of Abemaciclib in Dedifferentiated Liposarcoma

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

SarcomaDedifferentiated Liposarcoma

Interventions

DRUG

Abemaciclib

Trial Locations (1)

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER